AQP3 and intrahepatic cholangiocarcinoma: Especially, since naringenin has the highest CI (98.94%), JGT suggested that naringenin induces an increase in gastrointestinal movement factors, ICC markers (c-kit and SCF) and AQP3 to increase gastrointestinal motility in relieving FD.